UPDATE 1-Alnylam's gene silencing drug wins FDA approval
August 10, 2018 at 17:09 PM EDT
Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology.
